In last trading session, OptimizeRx Corp (NASDAQ:OPRX) saw 0.31 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share price level of $6.28 trading at $0.01 or 0.16% at ring of the bell on the day assigns it a market valuation of $115.06M. That closing price of OPRX’s stock is at a discount of -165.13% from its 52-week high price of $16.65 and is indicating a premium of 19.75% from its 52-week low price of $5.04. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 126.46K if we extend that period to 3-months.

For OptimizeRx Corp (OPRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.06 in the current quarter.

OptimizeRx Corp (NASDAQ:OPRX) trade information

Upright in the green during last session for gaining 0.16%, in the last five days OPRX remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $6.28 price level, adding 8.32% to its value on the day. OptimizeRx Corp’s shares saw a change of -56.11% in year-to-date performance and have moved 21.94% in past 5-day. OptimizeRx Corp (NASDAQ:OPRX) showed a performance of -4.41% in past 30-days. Number of shares sold short was 0.91 million shares which calculate 7.41 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 58.13% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -138.85% in reaching the projected high whereas dropping to the targeted low would mean a loss of -138.85% for stock’s current value.

OptimizeRx Corp (OPRX) estimates and forecasts

Statistics highlight that OptimizeRx Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -41.91% of value to its shares in past 6 months, showing an annual growth rate of 38.46% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 40.80% from the last financial year’s standing.

7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 25M for the same. And 7 analysts are in estimates of company making revenue of 37.08M in the next quarter. Company posted 15.15M and 28.37M of sales in current and next quarters respectively a year earlier.

OptimizeRx Corp (NASDAQ:OPRX)’s Major holders

Insiders are in possession of 13.35% of company’s total shares while institution are holding 76.72 percent of that, with stock having share float percentage of 88.55%. Investors also watch the number of corporate investors in a company very closely, which is 76.72% institutions for OptimizeRx Corp that are currently holding shares of the company. FIRST LIGHT ASSET MANAGEMENT, LLC is the top institutional holder at OPRX for having 1.83 million shares of worth $18.27 million. And as of 2024-06-30, it was holding 10.0548 of the company’s outstanding shares.

The second largest institutional holder is DIVISADERO STREET CAPITAL MANAGEMENT, LP, which was holding about 1.32 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.2422 of outstanding shares, having a total worth of $13.16 million.